Scarica l'app Stockscreener
15.05
6.89%
0.97
Dopo l'orario di chiusura:
15.20
0.15
+1.00%
Zymeworks Inc. Borsa (ZYME) Ultime notizie
Has Zymeworks Inc. found a price floorWeekly Gains Report & Capital Efficient Trade Techniques - Newser
Zymeworks Inc. $ZYME is EcoR1 Capital LLC's 3rd Largest Position - MarketBeat
What Fibonacci levels say about Zymeworks Inc. reboundTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
Trexquant Investment LP Has $2.63 Million Stake in Zymeworks Inc. $ZYME - MarketBeat
Real time breakdown of Zymeworks Inc. stock performanceWeekly Market Report & Long Hold Capital Preservation Tips - Newser
Zymeworks Inc. $ZYME Shares Sold by Wellington Management Group LLP - MarketBeat
What candlestick patterns are forming on Zymeworks Inc.New Guidance & Expert Approved Momentum Trade Ideas - Newser
Risk adjusted return profile for Zymeworks Inc. analyzedWeekly Trading Summary & Long-Term Investment Growth Plans - Newser
Heatmap analysis for Zymeworks Inc. and competitorsWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
What’s the fair value of Zymeworks Inc. stock2025 Valuation Update & Real-Time Market Trend Scan - خودرو بانک
How to build a custom watchlist for Zymeworks Inc.Market Growth Review & Detailed Earnings Play Strategies - Newser
Nuveen LLC Makes New $2.37 Million Investment in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Inc. $ZYME Shares Sold by Vanguard Group Inc. - MarketBeat
Custom watchlist performance reports with Zymeworks Inc.Dollar Strength & High Return Trade Opportunity Guides - Newser
Zymeworks Inc. stock trend forecast2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - Newser
Zymeworks Inc. (NYSE:ZYME) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
What is Zymeworks Inc.’s TAM (Total Addressable Market)Market Risk Summary & Community Supported Trade Ideas - خودرو بانک
Sentiment analysis tools applied to Zymeworks Inc.Market Weekly Review & Daily Stock Trend Watchlist - Newser
Zymeworks (NASDAQ:ZYME) Shares Gap DownWhat's Next? - MarketBeat
Zymeworks (NYSE:ZYME) Shares Gap DownTime to Sell? - MarketBeat
Detecting price anomalies in Zymeworks Inc. with AI2025 Sector Review & Fast Moving Stock Watchlists - Newser
50,000 Shares in Zymeworks Inc. $ZYME Acquired by ADAR1 Capital Management LLC - MarketBeat
Zymeworks Inc. $ZYME Shares Sold by Redmile Group LLC - MarketBeat
Vestal Point Capital LP Boosts Holdings in Zymeworks Inc. $ZYME - MarketBeat
Real time pattern detection on Zymeworks Inc. stock2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
Earnings Update: What is the earnings history of Zymeworks Inc.Product Launch & Weekly Stock Breakout Alerts - خودرو بانک
What momentum shifts mean for Zymeworks Inc.Rate Cut & AI Optimized Trading Strategy Guides - Newser
Tema Etfs LLC Purchases Shares of 33,001 Zymeworks Inc. $ZYME - MarketBeat
Sector ETF performance correlation with Zymeworks Inc.Risk Management & Free Technical Confirmation Trade Alerts - Newser
Why Zymeworks Inc. stock attracts strong analyst attention2025 Growth vs Value & Long-Term Growth Plans - Newser
S P Trends: Is Zymeworks Inc. forming a breakout patternMarket Trend Report & Consistent Profit Alerts - خودرو بانک
Zymeworks Inc. $ZYME Shares Sold by Walleye Capital LLC - MarketBeat
Zymeworks Inc. $ZYME Shares Bought by AlphaQuest LLC - MarketBeat
Is Zymeworks Inc. forming a breakout patternQuarterly Risk Review & Stepwise Trade Execution Plans - خودرو بانک
Zymeworks’ Pipeline Resilience Amid ZW171 Setback: Strategic Reallocation and ADC Innovation Drive Long-Term Value - AInvest
Zymeworks: Despite T-Cell Engager Setback, ADC Candidates Press On (NASDAQ:ZYME) - Seeking Alpha
Zymeworks Pulls Plug On Early-Stage Cancer Potential As Therapy Unlikely To Provide Benefit - AOL.com
Clinical Focus: Zymeworks Discontinues Development of ZW171 in Phase 1 Trial - Targeted Oncology
Is Zymeworks Inc. stock a good pick for beginnersJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - خودرو بانک
What machine learning models say about Zymeworks Inc.2025 Fundamental Recap & Community Driven Trade Alerts - Newser
Zymeworks Inc. shares fall 3.31% intraday after discontinuing clinical development of ZW171. - AInvest
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):